Do you want to volunteer for Clinical Trials? Register now

Volunteer for Clinical Trials

Have you ever thought about taking part in a Medical Trial? By registering your details with MedTrials.co.uk, we are able to send your details directly to companies who are looking for volunteers to take part in their medical research studies.

Information about you is kept on a register that CROs, Pharmaceutical companies and Clinical Investigators can access to contact you regarding individual studies.

Register now >

New Data On EMA401 In Model Of Diabetic Neuropathy Presented At 21st Annual NEURODIAB Meeting

Spinifex Pharmaceuticals, an Australian pain drug development company, today announces the presentation of new data from a study of EMA401 in a model of diabetic neuropathy. EMA401 is an angiotensin II type 2 (AT2) receptor antagonist currently in clinical development for a number of neuropathic pain indications…

Go to Source

Leave a Reply

News

Using the body clock to make drugs more effective

A new database of circadian changes in genetic expression can help physicians time drugs so that they’re synched up to the patient’s body clock. Powered by WPeMatico

more >

MS: New drug proven to slow brain shrinkage

A randomized, placebo-controlled trial shows that a new drug can reduce the atrophy of the brain, which is a hallmark of multiple sclerosis. Powered by WPeMatico

more >

Opioid crisis breakthrough: Non-addictive painkiller found effective

Researchers have developed a compound that simultaneously stops the addictive action of opioids and relieves chronic pain as effectively as morphine. Powered by WPeMatico

more >

New ‘triple pill’ could eliminate high blood pressure

Hypertension is very common, and it’s a major cardiovascular risk factor. An innovative ‘three in one’ pill may help treat it more easily and effectively. Powered by WPeMatico

more >

New technique treats prostate cancer in just five radiotherapy sessions

A new clinical trial proves the benefits of an innovative form of radiotherapy that reduces the treatment to five sessions instead of the usual 37. Powered by WPeMatico

more >

Fighting prostate cancer with groundbreaking new technique

Creating a way to keep prostate cancer cells alive in the laboratory for longer leads to quicker drug trials. Sharing this widely speeds it up further. Powered by WPeMatico

more >